| Gene Symbol | Gene ID | Gene Info | 
|---|---|---|
| 
                            ESR1
                            
                            
                         | ENSG00000091831.17 | estrogen receptor 1 | 
| CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot | 
|---|---|---|---|---|---|---|
| chr6_152011385_152011536 | ESR1 | 171 | 0.968833 | -0.80 | 1.0e-02 | Click! | 
| chr6_152012412_152012563 | ESR1 | 856 | 0.711449 | 0.79 | 1.1e-02 | Click! | 
| chr6_152023478_152023738 | ESR1 | 11977 | 0.261429 | -0.78 | 1.3e-02 | Click! | 
| chr6_152129326_152129477 | ESR1 | 587 | 0.795068 | 0.78 | 1.4e-02 | Click! | 
| chr6_152290545_152290696 | ESR1 | 88828 | 0.094008 | 0.78 | 1.4e-02 | Click! | 
Move your cursor over a bar to see sample name and corresponding Z-value.
| Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability | 
|---|---|---|---|---|---|
| chr11_20134359_20134761 | 0.80 | NAV2-AS1 | NAV2 antisense RNA 1 | 7618 | 0.23 | 
| chr3_159572255_159572681 | 0.75 | SCHIP1 | schwannomin interacting protein 1 | 1740 | 0.37 | 
| chr7_29605198_29605734 | 0.67 | PRR15 | proline rich 15 | 400 | 0.84 | 
| chr17_40670908_40671198 | 0.66 | ENSG00000265611 | . | 4847 | 0.09 | 
| chr1_36808619_36809165 | 0.66 | STK40 | serine/threonine kinase 40 | 18049 | 0.12 | 
| chr10_73605525_73605859 | 0.60 | ENSG00000238446 | . | 1141 | 0.49 | 
| chr10_81029619_81029967 | 0.58 | ZMIZ1 | zinc finger, MIZ-type containing 1 | 36182 | 0.19 | 
| chr5_1515989_1516747 | 0.58 | LPCAT1 | lysophosphatidylcholine acyltransferase 1 | 7724 | 0.23 | 
| chr8_10590583_10590855 | 0.55 | SOX7 | SRY (sex determining region Y)-box 7 | 2697 | 0.21 | 
| chr10_115438620_115438948 | 0.55 | CASP7 | caspase 7, apoptosis-related cysteine peptidase | 158 | 0.96 | 
| chr14_69407567_69407834 | 0.55 | ACTN1 | actinin, alpha 1 | 6565 | 0.25 | 
| chr14_105860468_105860995 | 0.55 | PACS2 | phosphofurin acidic cluster sorting protein 2 | 2935 | 0.17 | 
| chr20_30147783_30148009 | 0.52 | HM13-IT1 | HM13 intronic transcript 1 (non-protein coding) | 3073 | 0.16 | 
| chr14_59827605_59828209 | 0.51 | ENSG00000252869 | . | 38834 | 0.18 | 
| chr16_31142356_31142648 | 0.50 | RP11-388M20.2 |  | 252 | 0.77 | 
| chr18_43209000_43209203 | 0.49 | SLC14A2 | solute carrier family 14 (urea transporter), member 2 | 14335 | 0.2 | 
| chr3_183265897_183266131 | 0.45 | KLHL6-AS1 | KLHL6 antisense RNA 1 | 509 | 0.77 | 
| chr17_62151470_62151864 | 0.45 | ICAM2 | intercellular adhesion molecule 2 | 53673 | 0.09 | 
| chr7_92393722_92393991 | 0.44 | ENSG00000206763 | . | 62728 | 0.11 | 
| chr13_75990856_75991087 | 0.43 | TBC1D4-AS1 | TBC1D4 antisense RNA 1 | 39541 | 0.17 | 
| chr3_52105187_52105355 | 0.43 | LINC00696 | long intergenic non-protein coding RNA 696 | 7704 | 0.13 | 
| chr1_22258402_22258722 | 0.43 | HSPG2 | heparan sulfate proteoglycan 2 | 5228 | 0.16 | 
| chr1_9498721_9499110 | 0.41 | ENSG00000252956 | . | 1078 | 0.6 | 
| chr4_8192745_8193409 | 0.41 | SH3TC1 | SH3 domain and tetratricopeptide repeats 1 | 8014 | 0.22 | 
| chr17_55976704_55976873 | 0.41 | CUEDC1 | CUE domain containing 1 | 3962 | 0.21 | 
| chr1_6532022_6532173 | 0.41 | TNFRSF25 | tumor necrosis factor receptor superfamily, member 25 | 5842 | 0.12 | 
| chr1_153598933_153599084 | 0.41 | S100A13 | S100 calcium binding protein A13 | 516 | 0.52 | 
| chr9_137270522_137271255 | 0.41 | ENSG00000263897 | . | 369 | 0.9 | 
| chr14_69412745_69412910 | 0.40 | ACTN1 | actinin, alpha 1 | 1438 | 0.48 | 
| chr3_50355712_50356133 | 0.40 | HYAL2 | hyaluronoglucosaminidase 2 | 2457 | 0.1 | 
| chr16_11295208_11295453 | 0.40 | RMI2 | RecQ mediated genome instability 2 | 48176 | 0.08 | 
| chr22_43318424_43318765 | 0.40 | PACSIN2 | protein kinase C and casein kinase substrate in neurons 2 | 23285 | 0.2 | 
| chr6_20877296_20877733 | 0.40 | RP3-348I23.2 |  | 76589 | 0.12 | 
| chr14_89894960_89895143 | 0.40 | FOXN3-AS1 | FOXN3 antisense RNA 1 | 11353 | 0.17 | 
| chr1_55518675_55518972 | 0.40 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | 12928 | 0.2 | 
| chr2_9392225_9392385 | 0.39 | ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 45411 | 0.18 | 
| chr17_79971752_79971903 | 0.39 | ASPSCR1 | alveolar soft part sarcoma chromosome region, candidate 1 | 3140 | 0.09 | 
| chr17_36740635_36740786 | 0.39 | CTB-58E17.2 |  | 16592 | 0.13 | 
| chr14_103578139_103578290 | 0.39 | EXOC3L4 | exocyst complex component 3-like 4 | 4361 | 0.19 | 
| chr11_46360145_46360296 | 0.39 | DGKZ | diacylglycerol kinase, zeta | 72 | 0.97 | 
| chr20_61463306_61463766 | 0.38 | COL9A3 | collagen, type IX, alpha 3 | 14373 | 0.11 | 
| chr11_63640497_63640654 | 0.38 | MARK2 | MAP/microtubule affinity-regulating kinase 2 | 3827 | 0.17 | 
| chr10_30101231_30101626 | 0.38 | SVIL | supervillin | 76695 | 0.11 | 
| chr9_136996353_136996504 | 0.38 | WDR5 | WD repeat domain 5 | 4059 | 0.19 | 
| chr8_123928226_123928643 | 0.37 | ZHX2 | zinc fingers and homeoboxes 2 | 52810 | 0.12 | 
| chr1_27868563_27868910 | 0.37 | RP1-159A19.4 |  | 16420 | 0.16 | 
| chr8_129180533_129180792 | 0.37 | ENSG00000221261 | . | 18300 | 0.23 | 
| chr16_66544956_66545128 | 0.37 | TK2 | thymidine kinase 2, mitochondrial | 2644 | 0.17 | 
| chr22_30194899_30195349 | 0.37 | ASCC2 | activating signal cointegrator 1 complex subunit 2 | 2967 | 0.2 | 
| chr1_21588447_21588832 | 0.37 | RP3-329E20.2 |  | 3936 | 0.22 | 
| chr2_8640925_8641201 | 0.37 | AC011747.7 |  | 174833 | 0.03 | 
| chr2_9427415_9427711 | 0.36 | ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 80669 | 0.1 | 
| chr2_131111615_131111766 | 0.36 | PTPN18 | protein tyrosine phosphatase, non-receptor type 18 (brain-derived) | 1890 | 0.27 | 
| chr12_109115682_109115890 | 0.36 | CORO1C | coronin, actin binding protein, 1C | 8541 | 0.16 | 
| chr15_40627004_40627253 | 0.36 | C15orf52 | chromosome 15 open reading frame 52 | 3113 | 0.1 | 
| chr3_11243097_11243459 | 0.36 | HRH1 | histamine receptor H1 | 24439 | 0.24 | 
| chr20_34685745_34686271 | 0.36 | EPB41L1 | erythrocyte membrane protein band 4.1-like 1 | 5249 | 0.2 | 
| chr17_47533894_47534339 | 0.36 | NGFR | nerve growth factor receptor | 38539 | 0.1 | 
| chr14_65293424_65293575 | 0.36 | SPTB | spectrin, beta, erythrocytic | 3633 | 0.24 | 
| chr10_126029460_126029611 | 0.36 | OAT | ornithine aminotransferase | 77970 | 0.1 | 
| chr1_22258230_22258381 | 0.36 | HSPG2 | heparan sulfate proteoglycan 2 | 5485 | 0.16 | 
| chr9_137261966_137262247 | 0.36 | ENSG00000263897 | . | 9151 | 0.25 | 
| chr11_12088585_12089097 | 0.36 | MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 | 26702 | 0.22 | 
| chr8_142289717_142289880 | 0.35 | RP11-10J21.3 | Uncharacterized protein | 25134 | 0.12 | 
| chr19_41731212_41731363 | 0.35 | AXL | AXL receptor tyrosine kinase | 1373 | 0.29 | 
| chr1_184761453_184761811 | 0.35 | FAM129A | family with sequence similarity 129, member A | 13487 | 0.2 | 
| chr9_139257302_139257550 | 0.35 | DNLZ | DNL-type zinc finger | 745 | 0.51 | 
| chr17_55954346_55954647 | 0.35 | CUEDC1 | CUE domain containing 1 | 4465 | 0.2 | 
| chr3_50176368_50176664 | 0.35 | SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 15962 | 0.12 | 
| chr3_72235398_72235672 | 0.34 | ENSG00000212070 | . | 76044 | 0.12 | 
| chr17_79378177_79378500 | 0.34 | ENSG00000266392 | . | 3760 | 0.14 | 
| chr7_151385205_151385463 | 0.34 | PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 48015 | 0.15 | 
| chr1_42627613_42628057 | 0.34 | GUCA2A | guanylate cyclase activator 2A (guanylin) | 2554 | 0.29 | 
| chr14_69405435_69405631 | 0.34 | ACTN1 | actinin, alpha 1 | 8732 | 0.24 | 
| chr4_139327703_139328022 | 0.34 | SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 | 164359 | 0.04 | 
| chr11_62380549_62380700 | 0.34 | ROM1 | retinal outer segment membrane protein 1 | 377 | 0.4 | 
| chr21_38232225_38232376 | 0.34 | ENSG00000199806 | . | 8089 | 0.23 | 
| chr6_8083142_8083550 | 0.34 | EEF1E1 | eukaryotic translation elongation factor 1 epsilon 1 | 14198 | 0.22 | 
| chr6_15222233_15222384 | 0.34 | JARID2 | jumonji, AT rich interactive domain 2 | 24219 | 0.18 | 
| chr11_64878272_64878458 | 0.34 | VPS51 | vacuolar protein sorting 51 homolog (S. cerevisiae) | 411 | 0.47 | 
| chr8_96238091_96238242 | 0.34 | C8orf37 | chromosome 8 open reading frame 37 | 43263 | 0.17 | 
| chr20_1317307_1317796 | 0.33 | AL136531.1 | HCG2043693; Uncharacterized protein | 4 | 0.97 | 
| chr9_130906009_130906346 | 0.33 | LCN2 | lipocalin 2 | 5173 | 0.09 | 
| chr11_111609200_111609351 | 0.33 | PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 16487 | 0.17 | 
| chr22_30648620_30649241 | 0.33 | LIF | leukemia inhibitory factor | 6090 | 0.11 | 
| chr2_169426823_169427210 | 0.33 | ENSG00000265694 | . | 12437 | 0.23 | 
| chr19_2636442_2636925 | 0.33 | CTC-265F19.3 |  | 4731 | 0.15 | 
| chr1_47691411_47691617 | 0.33 | RP1-18D14.7 |  | 45 | 0.97 | 
| chr9_94533727_94534271 | 0.33 | ENSG00000266855 | . | 135466 | 0.05 | 
| chr2_43152306_43152732 | 0.33 | HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 132787 | 0.05 | 
| chr22_45625921_45626224 | 0.33 | KIAA0930 | KIAA0930 | 3288 | 0.23 | 
| chr4_151097529_151097680 | 0.33 | ENSG00000238721 | . | 33254 | 0.22 | 
| chr11_10609186_10609457 | 0.33 | MRVI1-AS1 | MRVI1 antisense RNA 1 | 5423 | 0.19 | 
| chr22_44759775_44760116 | 0.33 | RP1-32I10.10 | Uncharacterized protein | 1486 | 0.51 | 
| chr17_1655742_1656238 | 0.33 | SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 | 9263 | 0.1 | 
| chr1_3633020_3633399 | 0.33 | RP5-1092A11.2 |  | 2347 | 0.18 | 
| chr6_133085395_133085546 | 0.32 | VNN2 | vanin 2 | 872 | 0.48 | 
| chr18_46510269_46510564 | 0.32 | SMAD7 | SMAD family member 7 | 33335 | 0.16 | 
| chr1_151579139_151579290 | 0.32 | SNX27 | sorting nexin family member 27 | 5344 | 0.12 | 
| chr10_80850413_80850863 | 0.32 | ZMIZ1 | zinc finger, MIZ-type containing 1 | 21846 | 0.22 | 
| chr17_55967739_55968110 | 0.32 | CUEDC1 | CUE domain containing 1 | 2125 | 0.29 | 
| chr19_5260963_5261211 | 0.32 | PTPRS | protein tyrosine phosphatase, receptor type, S | 25087 | 0.21 | 
| chr9_96919191_96919602 | 0.32 | ENSG00000199165 | . | 18838 | 0.15 | 
| chr9_124032094_124032357 | 0.32 | GSN | gelsolin | 1845 | 0.28 | 
| chr20_1842593_1842744 | 0.32 | SIRPA | signal-regulatory protein alpha | 32486 | 0.19 | 
| chr21_44614410_44614785 | 0.32 | CRYAA | crystallin, alpha A | 24331 | 0.16 | 
| chr2_65608934_65609351 | 0.32 | AC012370.2 |  | 1323 | 0.48 | 
| chr22_37908037_37908429 | 0.32 | CARD10 | caspase recruitment domain family, member 10 | 15 | 0.97 | 
| chr11_19941032_19941183 | 0.32 | NAV2-AS3 | NAV2 antisense RNA 3 | 61776 | 0.13 | 
| chr1_28455497_28456106 | 0.31 | ENSG00000253005 | . | 13551 | 0.13 | 
| chr17_55981324_55981475 | 0.31 | CUEDC1 | CUE domain containing 1 | 649 | 0.69 | 
| chr16_70740874_70741025 | 0.31 | VAC14 | Vac14 homolog (S. cerevisiae) | 6801 | 0.15 | 
| chr7_129912749_129913103 | 0.31 | CPA2 | carboxypeptidase A2 (pancreatic) | 6259 | 0.15 | 
| chr14_69409711_69409862 | 0.31 | ACTN1 | actinin, alpha 1 | 4479 | 0.27 | 
| chr16_638089_638338 | 0.31 | RAB40C | RAB40C, member RAS oncogene family | 1144 | 0.24 | 
| chr9_14273530_14273681 | 0.31 | NFIB | nuclear factor I/B | 34407 | 0.21 | 
| chr19_11252797_11253239 | 0.31 | SPC24 | SPC24, NDC80 kinetochore complex component | 13419 | 0.13 | 
| chr2_241327570_241327721 | 0.31 | GPC1 | glypican 1 | 47443 | 0.12 | 
| chr3_119854481_119854726 | 0.31 | ENSG00000244139 | . | 13847 | 0.18 | 
| chr8_56861171_56861322 | 0.31 | LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 8453 | 0.16 | 
| chrX_152084026_152084274 | 0.31 | ZNF185 | zinc finger protein 185 (LIM domain) | 1116 | 0.5 | 
| chr1_16083104_16083325 | 0.31 | FBLIM1 | filamin binding LIM protein 1 | 60 | 0.95 | 
| chr6_7165580_7166040 | 0.31 | RP11-405O10.2 |  | 17506 | 0.17 | 
| chr8_61862675_61863209 | 0.31 | CLVS1 | clavesin 1 | 106775 | 0.07 | 
| chr11_67805590_67806035 | 0.31 | TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 671 | 0.53 | 
| chr22_25460867_25461018 | 0.31 | KIAA1671 | KIAA1671 | 4994 | 0.26 | 
| chr6_138291326_138291739 | 0.31 | RP11-356I2.4 |  | 102162 | 0.07 | 
| chr7_139426374_139426898 | 0.30 | HIPK2 | homeodomain interacting protein kinase 2 | 4795 | 0.29 | 
| chr13_31438557_31438708 | 0.30 | MEDAG | mesenteric estrogen-dependent adipogenesis | 41696 | 0.16 | 
| chr22_19161927_19162579 | 0.30 | AC004463.6 |  | 3345 | 0.15 | 
| chr17_42423914_42424082 | 0.30 | GRN | granulin | 1325 | 0.25 | 
| chr15_62737179_62737605 | 0.30 | TLN2 | talin 2 | 116172 | 0.06 | 
| chr9_125156330_125156481 | 0.30 | AL162424.1 | Uncharacterized protein | 7477 | 0.13 | 
| chr2_121943870_121944021 | 0.30 | TFCP2L1 | transcription factor CP2-like 1 | 98838 | 0.08 | 
| chr7_55253756_55253907 | 0.30 | EGFR-AS1 | EGFR antisense RNA 1 | 2796 | 0.38 | 
| chr8_42409885_42410036 | 0.30 | SMIM19 | small integral membrane protein 19 | 8389 | 0.18 | 
| chr1_28517417_28517723 | 0.30 | PTAFR | platelet-activating factor receptor | 2814 | 0.15 | 
| chr13_52412121_52412530 | 0.30 | CCDC70 | coiled-coil domain containing 70 | 23792 | 0.17 | 
| chr3_132757241_132757419 | 0.30 | TMEM108 | transmembrane protein 108 | 69 | 0.99 | 
| chr11_65257627_65258285 | 0.30 | SCYL1 | SCY1-like 1 (S. cerevisiae) | 34592 | 0.08 | 
| chr1_203172034_203172338 | 0.30 | CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 16309 | 0.13 | 
| chr9_91390340_91390723 | 0.30 | ENSG00000265873 | . | 29711 | 0.24 | 
| chr22_20191302_20191696 | 0.30 | XXbac-B444P24.8 |  | 942 | 0.46 | 
| chr3_45589006_45589723 | 0.30 | LARS2-AS1 | LARS2 antisense RNA 1 | 38327 | 0.14 | 
| chr17_72782415_72782574 | 0.30 | TMEM104 | transmembrane protein 104 | 9835 | 0.11 | 
| chr16_2211619_2211770 | 0.29 | TRAF7 | TNF receptor-associated factor 7, E3 ubiquitin protein ligase | 1849 | 0.12 | 
| chr14_93403837_93403988 | 0.29 | CHGA | chromogranin A (parathyroid secretory protein 1) | 14391 | 0.25 | 
| chr11_33963443_33963781 | 0.29 | LMO2 | LIM domain only 2 (rhombotin-like 1) | 49776 | 0.14 | 
| chr8_48343958_48344189 | 0.29 | SPIDR | scaffolding protein involved in DNA repair | 8890 | 0.29 | 
| chr15_33360065_33360419 | 0.29 | FMN1 | formin 1 | 121 | 0.98 | 
| chr3_63710485_63710636 | 0.29 | SNTN | sentan, cilia apical structure protein | 72186 | 0.09 | 
| chr17_76704134_76704285 | 0.29 | CYTH1 | cytohesin 1 | 8898 | 0.2 | 
| chr16_12282215_12282366 | 0.29 | SNX29 | sorting nexin 29 | 58736 | 0.11 | 
| chr1_160095186_160095337 | 0.29 | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 2201 | 0.19 | 
| chr17_74542392_74542689 | 0.29 | RP11-666A8.7 |  | 3493 | 0.09 | 
| chr1_3620112_3620445 | 0.29 | TP73 | tumor protein p73 | 5656 | 0.13 | 
| chr1_21620651_21620932 | 0.29 | ECE1 | endothelin converting enzyme 1 | 126 | 0.93 | 
| chr18_9704973_9705544 | 0.29 | RAB31 | RAB31, member RAS oncogene family | 2904 | 0.31 | 
| chr2_218793437_218793804 | 0.29 | TNS1 | tensin 1 | 8265 | 0.24 | 
| chr18_46517444_46517630 | 0.29 | RP11-15F12.1 |  | 32536 | 0.16 | 
| chr2_43466747_43467191 | 0.29 | AC010883.5 |  | 10257 | 0.23 | 
| chr6_17933009_17933323 | 0.29 | KIF13A | kinesin family member 13A | 54528 | 0.15 | 
| chr17_8762469_8762816 | 0.29 | PIK3R6 | phosphoinositide-3-kinase, regulatory subunit 6 | 8352 | 0.2 | 
| chr17_17740781_17741345 | 0.29 | SREBF1 | sterol regulatory element binding transcription factor 1 | 738 | 0.58 | 
| chr1_183250951_183251102 | 0.28 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | 22983 | 0.23 | 
| chr2_206809249_206809511 | 0.28 | ENSG00000201875 | . | 44026 | 0.13 | 
| chr7_906996_907156 | 0.28 | GET4 | golgi to ER traffic protein 4 homolog (S. cerevisiae) | 9113 | 0.15 | 
| chr18_43749824_43749975 | 0.28 | C18orf25 | chromosome 18 open reading frame 25 | 3620 | 0.25 | 
| chr3_112931713_112931990 | 0.28 | BOC | BOC cell adhesion associated, oncogene regulated | 442 | 0.86 | 
| chr14_35806722_35806916 | 0.28 | PSMA6 | proteasome (prosome, macropain) subunit, alpha type, 6 | 26780 | 0.19 | 
| chr11_95086535_95086686 | 0.28 | ENSG00000201204 | . | 119928 | 0.06 | 
| chr11_72896529_72896905 | 0.28 | RP11-800A3.2 |  | 30241 | 0.13 | 
| chr20_52235971_52236462 | 0.28 | ZNF217 | zinc finger protein 217 | 10785 | 0.21 | 
| chr6_167037122_167037303 | 0.28 | RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 3513 | 0.32 | 
| chr3_31857579_31857730 | 0.28 | OSBPL10 | oxysterol binding protein-like 10 | 13912 | 0.27 | 
| chr5_14204722_14204930 | 0.28 | TRIO | trio Rho guanine nucleotide exchange factor | 20919 | 0.29 | 
| chr5_176920924_176921139 | 0.28 | RP11-1334A24.6 |  | 965 | 0.35 | 
| chr4_41144342_41144612 | 0.28 | ENSG00000207198 | . | 28518 | 0.18 | 
| chr16_70425965_70426116 | 0.28 | ST3GAL2 | ST3 beta-galactoside alpha-2,3-sialyltransferase 2 | 8501 | 0.12 | 
| chr4_128544405_128544987 | 0.28 | INTU | inturned planar cell polarity protein | 270 | 0.95 | 
| chr6_90529041_90529192 | 0.28 | MDN1 | MDN1, midasin homolog (yeast) | 321 | 0.87 | 
| chr4_3487177_3487367 | 0.28 | RP11-529E10.6 |  | 18912 | 0.14 | 
| chr9_19999717_20000054 | 0.28 | ENSG00000266224 | . | 170134 | 0.03 | 
| chr1_61803481_61803729 | 0.28 | NFIA | nuclear factor I/A | 14517 | 0.3 | 
| chr3_197036693_197037063 | 0.28 | DLG1 | discs, large homolog 1 (Drosophila) | 10707 | 0.16 | 
| chr21_43352747_43353275 | 0.28 | C2CD2 | C2 calcium-dependent domain containing 2 | 6212 | 0.19 | 
| chr4_5638816_5638967 | 0.28 | EVC2 | Ellis van Creveld syndrome 2 | 71403 | 0.11 | 
| chr10_101946913_101947666 | 0.28 | ERLIN1 | ER lipid raft associated 1 | 802 | 0.51 | 
| chr6_82649464_82649641 | 0.28 | ENSG00000206886 | . | 175811 | 0.03 | 
| chr1_203482695_203483217 | 0.28 | OPTC | opticin | 17858 | 0.21 | 
| chr11_33963006_33963250 | 0.28 | LMO2 | LIM domain only 2 (rhombotin-like 1) | 49292 | 0.14 | 
| chr1_203194147_203194370 | 0.28 | CHIT1 | chitinase 1 (chitotriosidase) | 4541 | 0.19 | 
| chr16_9141084_9141235 | 0.28 | C16orf72 | chromosome 16 open reading frame 72 | 44346 | 0.12 | 
| chr17_76137750_76137971 | 0.28 | C17orf99 | chromosome 17 open reading frame 99 | 4574 | 0.12 | 
| chr16_85558860_85559293 | 0.28 | ENSG00000264203 | . | 83978 | 0.08 | 
| chr12_52400893_52401105 | 0.27 | GRASP | GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein | 275 | 0.87 | 
| chr5_140908442_140908593 | 0.27 | DIAPH1 | diaphanous-related formin 1 | 2803 | 0.16 | 
| chr8_65488684_65489072 | 0.27 | RP11-21C4.1 |  | 942 | 0.63 | 
| chr17_80607445_80607596 | 0.27 | WDR45B | WD repeat domain 45B | 1109 | 0.35 | 
| chr9_98275007_98275158 | 0.27 | RP11-435O5.4 |  | 1245 | 0.41 | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.2 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) | 
| 0.2 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) | 
| 0.2 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) | 
| 0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) | 
| 0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) | 
| 0.1 | 0.3 | GO:0060433 | bronchus development(GO:0060433) | 
| 0.1 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) | 
| 0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) | 
| 0.1 | 1.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) | 
| 0.1 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) | 
| 0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) | 
| 0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) | 
| 0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) | 
| 0.1 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) | 
| 0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) | 
| 0.1 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) | 
| 0.1 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) | 
| 0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) | 
| 0.1 | 0.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) | 
| 0.1 | 0.3 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) | 
| 0.1 | 0.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) | 
| 0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) | 
| 0.1 | 0.1 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) | 
| 0.1 | 0.2 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) | 
| 0.1 | 0.8 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) | 
| 0.1 | 0.2 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) | 
| 0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) | 
| 0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) | 
| 0.1 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) | 
| 0.1 | 0.2 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) | 
| 0.1 | 0.4 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) | 
| 0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) | 
| 0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) | 
| 0.1 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) | 
| 0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) | 
| 0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) | 
| 0.1 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) | 
| 0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) | 
| 0.1 | 0.2 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) | 
| 0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) | 
| 0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) | 
| 0.1 | 0.3 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) | 
| 0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) | 
| 0.1 | 0.1 | GO:0032632 | interleukin-3 production(GO:0032632) | 
| 0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) | 
| 0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) | 
| 0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) | 
| 0.1 | 0.3 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) | 
| 0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) | 
| 0.1 | 0.2 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) | 
| 0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) | 
| 0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) | 
| 0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) | 
| 0.1 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) | 
| 0.1 | 0.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) | 
| 0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) | 
| 0.1 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) | 
| 0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) | 
| 0.1 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) | 
| 0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) | 
| 0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) | 
| 0.1 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) | 
| 0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) | 
| 0.1 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) | 
| 0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) | 
| 0.1 | 0.1 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) | 
| 0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) | 
| 0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) | 
| 0.1 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) | 
| 0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) | 
| 0.1 | 0.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) | 
| 0.0 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) | 
| 0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) | 
| 0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) | 
| 0.0 | 0.0 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) | 
| 0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) | 
| 0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) | 
| 0.0 | 0.3 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) | 
| 0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) | 
| 0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) | 
| 0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) | 
| 0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) | 
| 0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) | 
| 0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) | 
| 0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) | 
| 0.0 | 0.0 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) | 
| 0.0 | 0.2 | GO:0032329 | serine transport(GO:0032329) | 
| 0.0 | 0.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) | 
| 0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) | 
| 0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) | 
| 0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) | 
| 0.0 | 0.4 | GO:0009629 | response to gravity(GO:0009629) | 
| 0.0 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) | 
| 0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) | 
| 0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) | 
| 0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) | 
| 0.0 | 0.0 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm development(GO:0048368) regulation of mesoderm development(GO:2000380) | 
| 0.0 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) | 
| 0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) | 
| 0.0 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) | 
| 0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) | 
| 0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) | 
| 0.0 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) | 
| 0.0 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) | 
| 0.0 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) | 
| 0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) | 
| 0.0 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) | 
| 0.0 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) | 
| 0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) | 
| 0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) | 
| 0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) | 
| 0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) | 
| 0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) | 
| 0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) | 
| 0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) | 
| 0.0 | 0.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) | 
| 0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) | 
| 0.0 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) | 
| 0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) | 
| 0.0 | 0.0 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) | 
| 0.0 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) | 
| 0.0 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) | 
| 0.0 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) | 
| 0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) | 
| 0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) | 
| 0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) | 
| 0.0 | 0.0 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) | 
| 0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) | 
| 0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) | 
| 0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) | 
| 0.0 | 0.1 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) | 
| 0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) | 
| 0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) | 
| 0.0 | 0.1 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) | 
| 0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) | 
| 0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) | 
| 0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) | 
| 0.0 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) | 
| 0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) | 
| 0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) | 
| 0.0 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) | 
| 0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) | 
| 0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) | 
| 0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) | 
| 0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) | 
| 0.0 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) | 
| 0.0 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) | 
| 0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) | 
| 0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) | 
| 0.0 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) | 
| 0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) | 
| 0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) | 
| 0.0 | 0.2 | GO:0051900 | regulation of membrane depolarization(GO:0003254) regulation of mitochondrial depolarization(GO:0051900) | 
| 0.0 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) | 
| 0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) | 
| 0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) | 
| 0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) | 
| 0.0 | 0.1 | GO:0045924 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) | 
| 0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) | 
| 0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) | 
| 0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) | 
| 0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) | 
| 0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) | 
| 0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) | 
| 0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) | 
| 0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) | 
| 0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) | 
| 0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) | 
| 0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) | 
| 0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) | 
| 0.0 | 0.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) | 
| 0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) | 
| 0.0 | 0.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) | 
| 0.0 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) | 
| 0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) | 
| 0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) | 
| 0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) | 
| 0.0 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) | 
| 0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) | 
| 0.0 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) | 
| 0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) | 
| 0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) | 
| 0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) | 
| 0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) | 
| 0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) | 
| 0.0 | 0.2 | GO:0090398 | cellular senescence(GO:0090398) | 
| 0.0 | 0.4 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) | 
| 0.0 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) | 
| 0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) | 
| 0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) | 
| 0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) | 
| 0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) | 
| 0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) | 
| 0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) | 
| 0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) | 
| 0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) | 
| 0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) | 
| 0.0 | 0.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) | 
| 0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) | 
| 0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) | 
| 0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) | 
| 0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) | 
| 0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) | 
| 0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) | 
| 0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) | 
| 0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) | 
| 0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) | 
| 0.0 | 0.2 | GO:0009309 | amine biosynthetic process(GO:0009309) | 
| 0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) | 
| 0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) | 
| 0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) | 
| 0.0 | 0.1 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) | 
| 0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) | 
| 0.0 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) | 
| 0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) | 
| 0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) | 
| 0.0 | 0.0 | GO:0034442 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) | 
| 0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) | 
| 0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) | 
| 0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) | 
| 0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) | 
| 0.0 | 0.3 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) | 
| 0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) | 
| 0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) | 
| 0.0 | 0.0 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) | 
| 0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) | 
| 0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) | 
| 0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) | 
| 0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) | 
| 0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) | 
| 0.0 | 0.2 | GO:0042116 | macrophage activation(GO:0042116) | 
| 0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) | 
| 0.0 | 0.0 | GO:0072216 | positive regulation of metanephros development(GO:0072216) | 
| 0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) | 
| 0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) | 
| 0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) | 
| 0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) | 
| 0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) | 
| 0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) | 
| 0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) | 
| 0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) | 
| 0.0 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) | 
| 0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) | 
| 0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) | 
| 0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) | 
| 0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) | 
| 0.0 | 0.0 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) | 
| 0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) | 
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) | 
| 0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) | 
| 0.0 | 0.0 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) | 
| 0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) | 
| 0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) | 
| 0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) | 
| 0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) | 
| 0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) | 
| 0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) | 
| 0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) | 
| 0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) | 
| 0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) | 
| 0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) | 
| 0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) | 
| 0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) | 
| 0.0 | 0.0 | GO:0070295 | renal water absorption(GO:0070295) | 
| 0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) | 
| 0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) | 
| 0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) | 
| 0.0 | 0.0 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) | 
| 0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) | 
| 0.0 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) | 
| 0.0 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) | 
| 0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) | 
| 0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) | 
| 0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) | 
| 0.0 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) | 
| 0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) | 
| 0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) | 
| 0.0 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) | 
| 0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) | 
| 0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) | 
| 0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) | 
| 0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) | 
| 0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) | 
| 0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) | 
| 0.0 | 0.2 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) | 
| 0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) | 
| 0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) | 
| 0.0 | 1.1 | GO:0006826 | iron ion transport(GO:0006826) | 
| 0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) | 
| 0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) | 
| 0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) | 
| 0.0 | 0.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) | 
| 0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) | 
| 0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) | 
| 0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) | 
| 0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) | 
| 0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) | 
| 0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) | 
| 0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) | 
| 0.0 | 0.1 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) | 
| 0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) | 
| 0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) | 
| 0.0 | 0.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) | 
| 0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) | 
| 0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) | 
| 0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) | 
| 0.0 | 0.1 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) | 
| 0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) | 
| 0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) | 
| 0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) | 
| 0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) | 
| 0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) | 
| 0.0 | 0.1 | GO:0019755 | one-carbon compound transport(GO:0019755) | 
| 0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) | 
| 0.0 | 0.0 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) | 
| 0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) | 
| 0.0 | 0.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) | 
| 0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) | 
| 0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) | 
| 0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) | 
| 0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) | 
| 0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) | 
| 0.0 | 0.1 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) | 
| 0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) | 
| 0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) | 
| 0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) | 
| 0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) | 
| 0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) | 
| 0.0 | 0.0 | GO:0032801 | receptor catabolic process(GO:0032801) | 
| 0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) | 
| 0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) | 
| 0.0 | 0.0 | GO:0007350 | blastoderm segmentation(GO:0007350) | 
| 0.0 | 0.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) | 
| 0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) | 
| 0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) | 
| 0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) | 
| 0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) | 
| 0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) | 
| 0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) | 
| 0.0 | 0.1 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) | 
| 0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) | 
| 0.0 | 0.1 | GO:0000090 | mitotic anaphase(GO:0000090) | 
| 0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) | 
| 0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) | 
| 0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) | 
| 0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) | 
| 0.0 | 0.1 | GO:0061035 | regulation of cartilage development(GO:0061035) | 
| 0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) | 
| 0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) | 
| 0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) | 
| 0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) | 
| 0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) | 
| 0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) | 
| 0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) | 
| 0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) | 
| 0.0 | 0.0 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) | 
| 0.0 | 0.2 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) | 
| 0.0 | 0.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) | 
| 0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) | 
| 0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) | 
| 0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) | 
| 0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) | 
| 0.0 | 0.2 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) | 
| 0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) | 
| 0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) | 
| 0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) | 
| 0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) | 
| 0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) | 
| 0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) | 
| 0.0 | 0.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) | 
| 0.0 | 0.1 | GO:0051570 | negative regulation of histone methylation(GO:0031061) regulation of histone H3-K9 methylation(GO:0051570) | 
| 0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) | 
| 0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) | 
| 0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) | 
| 0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) | 
| 0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) | 
| 0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) | 
| 0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) | 
| 0.0 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) | 
| 0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) | 
| 0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) | 
| 0.0 | 0.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) | 
| 0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) | 
| 0.0 | 0.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) | 
| 0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) | 
| 0.0 | 0.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) | 
| 0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) | 
| 0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) | 
| 0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) | 
| 0.0 | 0.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) | 
| 0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) | 
| 0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) | 
| 0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) | 
| 0.0 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) | 
| 0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) | 
| 0.0 | 1.1 | GO:0034329 | cell junction assembly(GO:0034329) | 
| 0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) | 
| 0.0 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) | 
| 0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) | 
| 0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) | 
| 0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) | 
| 0.0 | 0.1 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) | 
| 0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) | 
| 0.0 | 0.0 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) | 
| 0.0 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) | 
| 0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) | 
| 0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) | 
| 0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) | 
| 0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) | 
| 0.0 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) | 
| 0.0 | 0.2 | GO:0032006 | regulation of TOR signaling(GO:0032006) | 
| 0.0 | 0.1 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) | 
| 0.0 | 0.1 | GO:0021988 | olfactory lobe development(GO:0021988) | 
| 0.0 | 0.0 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) | 
| 0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) | 
| 0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) | 
| 0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) | 
| 0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) | 
| 0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) | 
| 0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) | 
| 0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) | 
| 0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) | 
| 0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) | 
| 0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) | 
| 0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) | 
| 0.0 | 0.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) | 
| 0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) | 
| 0.0 | 0.0 | GO:0090312 | positive regulation of histone deacetylation(GO:0031065) positive regulation of protein deacetylation(GO:0090312) | 
| 0.0 | 0.2 | GO:0046068 | cGMP metabolic process(GO:0046068) | 
| 0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) | 
| 0.0 | 0.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) | 
| 0.0 | 0.0 | GO:0045006 | DNA deamination(GO:0045006) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) | 
| 0.1 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) | 
| 0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) | 
| 0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) | 
| 0.1 | 0.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) | 
| 0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) | 
| 0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) | 
| 0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) | 
| 0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) | 
| 0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) | 
| 0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) | 
| 0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) | 
| 0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) | 
| 0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) | 
| 0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) | 
| 0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) | 
| 0.0 | 0.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) | 
| 0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) | 
| 0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) | 
| 0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) | 
| 0.0 | 0.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) | 
| 0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) | 
| 0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) | 
| 0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) | 
| 0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) | 
| 0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) | 
| 0.0 | 3.3 | GO:0005925 | focal adhesion(GO:0005925) | 
| 0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) | 
| 0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) | 
| 0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) | 
| 0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) | 
| 0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) | 
| 0.0 | 0.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) | 
| 0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) | 
| 0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) | 
| 0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) | 
| 0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) | 
| 0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) | 
| 0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) | 
| 0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) | 
| 0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) | 
| 0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) | 
| 0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) | 
| 0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) | 
| 0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) | 
| 0.0 | 0.9 | GO:0005912 | adherens junction(GO:0005912) | 
| 0.0 | 0.2 | GO:0042627 | chylomicron(GO:0042627) | 
| 0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) | 
| 0.0 | 0.0 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) | 
| 0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) | 
| 0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) | 
| 0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) | 
| 0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) | 
| 0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) | 
| 0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) | 
| 0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) | 
| 0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) | 
| 0.0 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) | 
| 0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) | 
| 0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) | 
| 0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) | 
| 0.0 | 0.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) | 
| 0.0 | 0.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) | 
| 0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) | 
| 0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) | 
| 0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) | 
| 0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) | 
| 0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) | 
| 0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) | 
| 0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) | 
| 0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) | 
| 0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) | 
| 0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) | 
| 0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) | 
| 0.0 | 0.4 | GO:0043204 | perikaryon(GO:0043204) | 
| 0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) | 
| 0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) | 
| 0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) | 
| 0.0 | 0.0 | GO:0031091 | platelet alpha granule(GO:0031091) | 
| 0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) | 
| 0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) | 
| 0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) | 
| 0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) | 
| 0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) | 
| 0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) | 
| 0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) | 
| 0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) | 
| 0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) | 
| 0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) | 
| 0.0 | 0.6 | GO:0030017 | sarcomere(GO:0030017) | 
| 0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) | 
| 0.0 | 1.3 | GO:0045095 | keratin filament(GO:0045095) | 
| 0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) | 
| 0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) | 
| 0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) | 
| 0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) | 
| 0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) | 
| 0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) | 
| 0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) | 
| 0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) | 
| 0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) | 
| 0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) | 
| 0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) | 
| 0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) | 
| 0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) | 
| 0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) | 
| 0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) | 
| 0.0 | 0.0 | GO:0032432 | actin filament bundle(GO:0032432) | 
| 0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) | 
| 0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) | 
| 0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) | 
| 0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) | 
| 0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) | 
| 0.0 | 0.4 | GO:0097223 | acrosomal vesicle(GO:0001669) sperm part(GO:0097223) | 
| 0.0 | 0.6 | GO:0005604 | basement membrane(GO:0005604) | 
| 0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) | 
| 0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) | 
| 0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) | 
| 0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) | 
| 0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) | 
| 0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) | 
| 0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) | 
| 0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) | 
| 0.0 | 0.0 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) | 
| 0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) | 
| 0.0 | 2.2 | GO:0005792 | obsolete microsome(GO:0005792) | 
| 0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) | 
| 0.2 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) | 
| 0.1 | 0.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) | 
| 0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) | 
| 0.1 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) | 
| 0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) | 
| 0.1 | 0.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) | 
| 0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) | 
| 0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) | 
| 0.1 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) | 
| 0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) | 
| 0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) | 
| 0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) | 
| 0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) | 
| 0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) | 
| 0.1 | 0.3 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) | 
| 0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) | 
| 0.1 | 0.3 | GO:0008061 | chitin binding(GO:0008061) | 
| 0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) | 
| 0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) | 
| 0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) | 
| 0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) | 
| 0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) | 
| 0.1 | 0.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) | 
| 0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) | 
| 0.1 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) | 
| 0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) | 
| 0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) | 
| 0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) | 
| 0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) | 
| 0.1 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) | 
| 0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) | 
| 0.1 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) | 
| 0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) | 
| 0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) | 
| 0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) | 
| 0.1 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) | 
| 0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) | 
| 0.1 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) | 
| 0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) | 
| 0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) | 
| 0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) | 
| 0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) | 
| 0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) | 
| 0.1 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) | 
| 0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) | 
| 0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) | 
| 0.1 | 0.5 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) | 
| 0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) | 
| 0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) | 
| 0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) | 
| 0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) | 
| 0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) | 
| 0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) | 
| 0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) | 
| 0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) | 
| 0.0 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) | 
| 0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) | 
| 0.0 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) | 
| 0.0 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) | 
| 0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) | 
| 0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) | 
| 0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) | 
| 0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) | 
| 0.0 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) | 
| 0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) | 
| 0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) | 
| 0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) | 
| 0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) | 
| 0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) | 
| 0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) | 
| 0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) | 
| 0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) | 
| 0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) | 
| 0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) | 
| 0.0 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) | 
| 0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) | 
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) | 
| 0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) | 
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) | 
| 0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) | 
| 0.0 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) | 
| 0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) | 
| 0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) | 
| 0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) | 
| 0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) | 
| 0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) | 
| 0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) | 
| 0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) | 
| 0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) | 
| 0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) | 
| 0.0 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) | 
| 0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) | 
| 0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) | 
| 0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) | 
| 0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) | 
| 0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) | 
| 0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) | 
| 0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) | 
| 0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) | 
| 0.0 | 0.1 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) | 
| 0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) | 
| 0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) | 
| 0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) | 
| 0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) | 
| 0.0 | 0.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) | 
| 0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) | 
| 0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) | 
| 0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) | 
| 0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) | 
| 0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) | 
| 0.0 | 1.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) | 
| 0.0 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) | 
| 0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) | 
| 0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) | 
| 0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) | 
| 0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) | 
| 0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) | 
| 0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) | 
| 0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) | 
| 0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) | 
| 0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) | 
| 0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) | 
| 0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) | 
| 0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) | 
| 0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) | 
| 0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) | 
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) | 
| 0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) | 
| 0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) | 
| 0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) | 
| 0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) | 
| 0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) | 
| 0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) | 
| 0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) | 
| 0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) | 
| 0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) | 
| 0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) | 
| 0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) | 
| 0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) | 
| 0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) | 
| 0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) | 
| 0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) | 
| 0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) | 
| 0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) | 
| 0.0 | 0.4 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) | 
| 0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) | 
| 0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) | 
| 0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) | 
| 0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) | 
| 0.0 | 0.1 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) | 
| 0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) | 
| 0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) | 
| 0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) | 
| 0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) | 
| 0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) | 
| 0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) | 
| 0.0 | 0.1 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) | 
| 0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) | 
| 0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) | 
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) | 
| 0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) | 
| 0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) | 
| 0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) | 
| 0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) | 
| 0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) | 
| 0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) | 
| 0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) | 
| 0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) | 
| 0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) | 
| 0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) | 
| 0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) | 
| 0.0 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) | 
| 0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) | 
| 0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) | 
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) | 
| 0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) | 
| 0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) | 
| 0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) | 
| 0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) | 
| 0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) | 
| 0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) | 
| 0.0 | 0.0 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) | 
| 0.0 | 0.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) | 
| 0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) | 
| 0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) | 
| 0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) | 
| 0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) | 
| 0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) | 
| 0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) | 
| 0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) | 
| 0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) | 
| 0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) | 
| 0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) | 
| 0.0 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) | 
| 0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) | 
| 0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) | 
| 0.0 | 0.1 | GO:0008253 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) | 
| 0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) | 
| 0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) | 
| 0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) | 
| 0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) | 
| 0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) | 
| 0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) | 
| 0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) | 
| 0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) | 
| 0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) | 
| 0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) | 
| 0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) | 
| 0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) | 
| 0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) | 
| 0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) | 
| 0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) | 
| 0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) | 
| 0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) | 
| 0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) | 
| 0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) | 
| 0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) | 
| 0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) | 
| 0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) | 
| 0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) | 
| 0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) | 
| 0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) | 
| 0.0 | 0.1 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) | 
| 0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) | 
| 0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) | 
| 0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) | 
| 0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) | 
| 0.0 | 0.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) | 
| 0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) | 
| 0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) | 
| 0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) | 
| 0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) | 
| 0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) | 
| 0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) | 
| 0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) | 
| 0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) | 
| 0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) | 
| 0.0 | 0.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) | 
| 0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) | 
| 0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) | 
| 0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) | 
| 0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) | 
| 0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) | 
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) | 
| 0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) | 
| 0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) | 
| 0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) | 
| 0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) | 
| 0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) | 
| 0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) | 
| 0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) | 
| 0.0 | 0.0 | GO:0046980 | tapasin binding(GO:0046980) | 
| 0.0 | 0.5 | GO:0002020 | protease binding(GO:0002020) | 
| 0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) | 
| 0.0 | 0.0 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) | 
| 0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) | 
| 0.0 | 0.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) | 
| 0.0 | 0.1 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) | 
| 0.0 | 0.1 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) | 
| 0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) | 
| 0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) | 
| 0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) | 
| 0.0 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) | 
| 0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) | 
| 0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) | 
| 0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) | 
| 0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) | 
| 0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) | 
| 0.0 | 0.0 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) | 
| 0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) | 
| 0.0 | 0.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) | 
| 0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) | 
| 0.0 | 0.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) | 
| 0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) | 
| 0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) | 
| 0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) | 
| 0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) | 
| 0.0 | 0.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) | 
| 0.0 | 0.3 | GO:0019003 | GDP binding(GO:0019003) | 
| 0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) | 
| 0.0 | 0.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) | 
| 0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) | 
| 0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) | 
| 0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) | 
| 0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) | 
| 0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) | 
| 0.0 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) | 
| 0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) | 
| 0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) | 
| 0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) | 
| 0.0 | 0.2 | GO:0004532 | exoribonuclease activity(GO:0004532) | 
| 0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) | 
| 0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) | 
| 0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.2 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes | 
| 0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes | 
| 0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events | 
| 0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase | 
| 0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events | 
| 0.0 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events | 
| 0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor | 
| 0.0 | 1.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction | 
| 0.0 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway | 
| 0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway | 
| 0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network | 
| 0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway | 
| 0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway | 
| 0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. | 
| 0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway | 
| 0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway | 
| 0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events | 
| 0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions | 
| 0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta | 
| 0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta | 
| 0.0 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway | 
| 0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. | 
| 0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma | 
| 0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling | 
| 0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP | 
| 0.0 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events | 
| 0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes | 
| 0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling | 
| 0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family | 
| 0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events | 
| 0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions | 
| 0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway | 
| 0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling | 
| 0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events | 
| 0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events | 
| 0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway | 
| 0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans | 
| 0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network | 
| 0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway | 
| 0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events | 
| 0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway | 
| 0.0 | 0.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte | 
| 0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway | 
| 0.0 | 0.1 | PID EPHA FWDPATHWAY | EPHA forward signaling | 
| 0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. | 
| 0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling | 
| 0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events | 
| 0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway | 
| 0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 | 
| 0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway | 
| 0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. | 
| 0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway | 
| 0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway | 
| 0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling | 
| 0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes | 
| 0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway | 
| 0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton | 
| 0.0 | 0.1 | PID ATM PATHWAY | ATM pathway | 
| 0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway | 
| 0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt | 
| 0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway | 
| 0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network | 
| 0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals | 
| 0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling | 
| 0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling | 
| 0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network | 
| 0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network | 
| Log-likelihood per target | Total log-likelihood | Term | Description | 
|---|---|---|---|
| 0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions | 
| 0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion | 
| 0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 
| 0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions | 
| 0.1 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling | 
| 0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane | 
| 0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors | 
| 0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 | 
| 0.0 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling | 
| 0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis | 
| 0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis | 
| 0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC | 
| 0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters | 
| 0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac | 
| 0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling | 
| 0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors | 
| 0.0 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity | 
| 0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 | 
| 0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport | 
| 0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules | 
| 0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling | 
| 0.0 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle | 
| 0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction | 
| 0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions | 
| 0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor | 
| 0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters | 
| 0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism | 
| 0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | 
| 0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins | 
| 0.0 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets | 
| 0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL | 
| 0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha | 
| 0.0 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis | 
| 0.0 | 0.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) | 
| 0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis | 
| 0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease | 
| 0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 | 
| 0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions | 
| 0.0 | 0.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane | 
| 0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors | 
| 0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism | 
| 0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters | 
| 0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines | 
| 0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination | 
| 0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors | 
| 0.0 | 0.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis | 
| 0.0 | 1.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization | 
| 0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation | 
| 0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones | 
| 0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition | 
| 0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen | 
| 0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) | 
| 0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 
| 0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis | 
| 0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo | 
| 0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle | 
| 0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA | 
| 0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols | 
| 0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation | 
| 0.0 | 0.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling | 
| 0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors | 
| 0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins | 
| 0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins | 
| 0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide | 
| 0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling | 
| 0.0 | 0.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling | 
| 0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix | 
| 0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism | 
| 0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation | 
| 0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression | 
| 0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 | 
| 0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 
| 0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling | 
| 0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes | 
| 0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) | 
| 0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation | 
| 0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism | 
| 0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins | 
| 0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling | 
| 0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism | 
| 0.0 | 0.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation | 
| 0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 
| 0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis | 
| 0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis | 
| 0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network | 
| 0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation | 
| 0.0 | 0.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 
| 0.0 | 0.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) | 
| 0.0 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation | 
| 0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane | 
| 0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival | 
| 0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript | 
| 0.0 | 0.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis | 
| 0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events | 
| 0.0 | 0.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 
| 0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis | 
| 0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |